A cancer patient in her 70s has become the first person in Taiwan to have costly chimeric antigen receptor (CAR) T-cell therapy covered by the National Health Insurance (NHI) system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Court orders release of Ko Wen-je after indictment
12/27/2024 10:24 AM - Business
U.S. dollar higher in Taipei trading
12/27/2024 10:16 AM - Business
Taiwan shares open higher
12/27/2024 09:10 AM - Politics
TSMC investment drives Kaohsiung's urban development: Mayor
12/26/2024 09:12 PM - Cross-Strait
NIA stops 124 Chinese nationals from visiting Taiwan using forged documents
12/26/2024 08:53 PM